BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 7007887)

  • 1. Relationship of glicentin to proglucagon and glucagon in the porcine pancreas.
    Moody AJ; Holst JJ; Thim L; Jensen SL
    Nature; 1981 Feb; 289(5797):514-6. PubMed ID: 7007887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The primary structure of porcine glicentin (proglucagon).
    Thim L; Moody AJ
    Regul Pept; 1981 May; 2(2):139-50. PubMed ID: 6894800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proglucagon processing in an islet cell line: effects of PC1 overexpression and PC2 depletion.
    Dhanvantari S; Brubaker PL
    Endocrinology; 1998 Apr; 139(4):1630-7. PubMed ID: 9528943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The amino acid sequence of porcine glicentin.
    Thim L; Moody AJ
    Peptides; 1981; 2 Suppl 2():37-9. PubMed ID: 7045833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proglucagon processing in porcine and human pancreas.
    Holst JJ; Bersani M; Johnsen AH; Kofod H; Hartmann B; Orskov C
    J Biol Chem; 1994 Jul; 269(29):18827-33. PubMed ID: 8034635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular forms of glucagon-like immunoreactivity in porcine intestine and pancreas.
    Ghatei MA; Uttenthal LO; Bryant MG; Christofides ND; Moody AJ; Bloom SR
    Endocrinology; 1983 Mar; 112(3):917-23. PubMed ID: 6822217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification and chemical characterization of a glicentin-related pancreatic peptide (proglucagon fragment) from porcine pancreas.
    Thim L; Moody AJ
    Biochim Biophys Acta; 1982 May; 703(2):134-41. PubMed ID: 7082677
    [No Abstract]   [Full Text] [Related]  

  • 8. Proglucagon processing in islet and intestinal cell lines.
    Tucker JD; Dhanvantari S; Brubaker PL
    Regul Pept; 1996 Apr; 62(1):29-35. PubMed ID: 8738879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proglucagon is processed to glucagon by prohormone convertase PC2 in alpha TC1-6 cells.
    Rouillé Y; Westermark G; Martin SK; Steiner DF
    Proc Natl Acad Sci U S A; 1994 Apr; 91(8):3242-6. PubMed ID: 8159732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of glicentin-related peptides on glucagon secretion in anaesthetized dogs.
    Ohneda A; Kobayashi T; Nihei J
    Diabetologia; 1986 Jun; 29(6):397-401. PubMed ID: 3527839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of prohormone convertases in the tissue-specific processing of proglucagon.
    Dhanvantari S; Seidah NG; Brubaker PL
    Mol Endocrinol; 1996 Apr; 10(4):342-55. PubMed ID: 8721980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastric inhibitory peptide-like immunoreactivity in glucagon and glicentin cells: properties and origin. An immunocytochemical study using several antisera.
    Sjölund K; Ekelund M; Håkanson R; Moody AJ; Sundler F
    J Histochem Cytochem; 1983 Jun; 31(6):811-7. PubMed ID: 6188783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucagon and glicentin immunoreactivity are topologically segregated in the alpha granule of the human pancreatic A cell.
    Ravazzola M; Orci L
    Nature; 1980 Mar; 284(5751):66-7. PubMed ID: 6986567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of glicentin-related peptides upon the secretion of insulin and glucagon in the canine pancreas.
    Ohneda A; Ohneda M
    Tohoku J Exp Med; 1988 Jun; 155(2):197-204. PubMed ID: 3062845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biochemical characterization of proglucagon-related peptides.
    Yanaihara N; Mochizuki T; Satoh T; Imai S; Sasaki K; Kakuyama H; Hosoe H; Takatsuka N; Iguchi K; Luo WQ; Kurokawa N; Yanaihara C
    Ann N Y Acad Sci; 1996 Dec; 805():20-9; discussion 29-30. PubMed ID: 8993390
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of the prohormone convertase PC3 in the processing of proglucagon to glucagon-like peptide 1.
    Rouillé Y; Kantengwa S; Irminger JC; Halban PA
    J Biol Chem; 1997 Dec; 272(52):32810-6. PubMed ID: 9407057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localization of glucagon-like peptide (GLP) immunoreactants in human gut and pancreas using light and electron microscopic immunocytochemistry.
    Varndell IM; Bishop AE; Sikri KL; Uttenthal LO; Bloom SR; Polak JM
    J Histochem Cytochem; 1985 Oct; 33(10):1080-6. PubMed ID: 3900195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation and chemical characterization of glicentin C-terminal hexapeptide in porcine pancreas.
    Yanaihara C; Matsumoto T; Hong YM; Yanaihara N
    FEBS Lett; 1985 Sep; 189(1):50-6. PubMed ID: 4029398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of an oxyntomodulin/glicentin C-terminal radioimmunoassay using a "thiol-maleoyl" coupling method for preparing the immunogen.
    Blache P; Kervran A; Martinez J; Bataille D
    Anal Biochem; 1988 Aug; 173(1):151-9. PubMed ID: 3189794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of pancreatic glucagon gene expression in mice bearing a subcutaneous glucagon-producing GLUTag transplantable tumor.
    Drucker DJ; Lee YC; Asa SL; Brubaker PL
    Mol Endocrinol; 1992 Dec; 6(12):2175-84. PubMed ID: 1491697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.